CIK 0001708599 · Non-accelerated filer<br>Smaller reporting company
Serina Therapeutics, Inc.
Sign in to watch- Ticker
- SER
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- AL
- Entity type
- operating
- EIN
- 821436829
- Phone
- (256) 327-9630
- Business address
- 601 GENOME WAY, SUITE 2001, HUNTSVILLE, AL, 35806
- Former names
- AgeX Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 43 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-11 | WEST MICHAEL D Chief Executive Officer | Shares withheld for taxes | −1,081 | $0.59 | $638 | 39,917 |
| 2022-12-11 | WEST MICHAEL D Chief Executive Officer | Option exercise · Restricted Stock Units | −3,125 | 3,125 | ||
| 2022-10-26 | Juvenescence Ltd Director | Grant or award · Warrant to Purchase Common Stock | +362,318 | 362,318 |
Page 12 of 12 · 223 trades